Grigoris Gerotziafas: DU T2H 2026–2027 Enrolment Is Now Open
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn:
“Second Announcement – DU T2H 2026-2027 Enrolment Now Open
Places are limited for the next intake of the University Diploma in Thrombosis and Haemostasis, Diagnosis and Therapy (DU T2H) at Sorbonne University .
This bilingual (French and English) programme brings together 53 international experts from 19 countries to deliver a unique blend of scientific excellence and clinical practice across 11 comprehensive modules — from risk stratification and precision thrombosis strategies to bleeding disorders, cancer-associated thrombosis, and pregnancy-related VTE.
- Academic certification from a world-leading university
- Fully compatible with professional activity
- Online interactive learning (Moodle with live Zoom workshops)
- Real-life, multidisciplinary clinical case discussions
Designed for professionals in haematology, vascular medicine, oncology, internal medicine, obstetrics, surgery, intensive care, and beyond.
Applications are open – reach out for details on how to apply.”
Stay updated with Hemostasis Today.
-
Aug 10, 2026, 08:41Gut Microbiota and Platelet Recovery After Radiation – Platelets Journal
-
Aug 10, 2026, 06:06Mostafa Faisal: What Does High Ferritin Really Mean
-
Aug 10, 2026, 05:45Colin Holburn: Key Laboratory Clues to End Organ Damage
-
Aug 10, 2026, 05:35George Dimitrov: SII and Cancer – What Can This Marker Really Tell Us
-
Aug 10, 2026, 05:01Emicizumab and Breastfeeding New Clinical Evidence – JTH
-
Aug 10, 2026, 04:53Abdulaziz Elnusiry: Pulmonary Embolism – The Silent Emergency We Need to Talk About
-
Aug 10, 2026, 04:33Saba Javed: Managing VTE in Cancer Patients With Thrombocytopenia
-
Aug 10, 2026, 04:21Heghine Khachatryan: When Cancer Is Not Enough to Predict VTE Risk
-
Aug 10, 2026, 04:09Ney Carter Borges: How Polyphenols Influence Endothelial Function